- 全部删除
您的购物车当前为空
TD139 是一种吸入式半乳糖凝集素-3 (Gal-3) 的小分子抑制剂,具有潜在的抗纤维化活性,常被用于研究特发性肺纤维化。


为众多的药物研发团队赋能,
让新药发现更简单!
TD139 是一种吸入式半乳糖凝集素-3 (Gal-3) 的小分子抑制剂,具有潜在的抗纤维化活性,常被用于研究特发性肺纤维化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 540 | In stock | |
| 5 mg | ¥ 1,060 | In stock | |
| 10 mg | ¥ 1,720 | In stock | |
| 25 mg | ¥ 3,620 | In stock | |
| 50 mg | ¥ 5,160 | In stock | |
| 100 mg | ¥ 6,950 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,520 | In stock |
TD139 相关产品
| 产品描述 | TD139 is a small molecule inhibitor of inhaled galectin-3 (Gal-3) with potential anti-fibrotic activity, commonly used in the study of idiopathic pulmonary fibrosis. |
| 靶点活性 | Galectin-3:7.9 μg/mL, GAL3:0.036 µM (Kd), GAL3:14 nM (Kd) |
| 体外活性 | 方法:小鼠的原代肺泡上皮细胞用 TGF-β1 (1-3 ng/mL) 和 TD139 (10 µM) 处理,通过 Western Blot 检测靶点蛋白表达水平。 |
| 体内活性 | 方法:为研究对 bleomycin 诱导的肺损伤纤维化期的影响,将 TD139 (10 µg) 气管内滴注给肺纤维化小鼠肺部,每两天一次,给药四次。 |
| 分子量 | 648.64 |
| 分子式 | C28H30F2N6O8S |
| CAS No. | 1450824-22-2 |
| Smiles | OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)n2cc(nn2)-c2cccc(F)c2)[C@H](O)[C@H]([C@H]1O)n1cc(nn1)-c1cccc(F)c1 |
| 密度 | 1.76 g/cm3 (Predicted) |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: Insoluble Ethanol: 3 mg/mL (4.63 mM), Sonication is recommended. DMSO: 55 mg/mL (84.79 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.08 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| ||||||||||||||||||||||||||||||||||||

Crystal Structure of Human Galectin-7 in Complex with TD139
评论内容